TP53 and Cestode infectious disease: Niclosamide, an oral anthelminthic medication used to treat tapeworm infections since 1960, has also been tested in vitro in TP53-mutated AML patient samples and cell lines, exhibiting potential anti-leukemic activity and restoration of sensitivity of these cells to hypomethylating therapy [153].